BUY Sai Life Sciences — Rajesh Satpute
byRajesh SatputeHorizon: NA (inferred Swing (≤2wk))30 Oct 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·7 Nov · today
Past week's volume 3.4× the 30-day average
Technicals · volume·6 Nov · yesterday
Sai Life Sciences reported Q2 FY27 revenue growth of 23% YoY and H1 FY27 revenue growth of 17% YoY, with EBITDA and PAT also showing growth compared to the previous year.
BSE · Company Update·6 Nov · yesterday
JK Agri Genetics sells leasehold rights to Sai Life Sciences for ₹19.80 crore
NewsGoogle News·30 Oct · 1w ago
Sai Life Sciences Gets 'Buy' Rating As PL Capital Initiates Coverage; Check Target Price
NewsNdtv-Profit·22 Oct · 2w ago
Nothing found in this tip’s window yet.
RSI at 93 — overbought territory
Technicals · rsi·7 Nov · today
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Sai Life Sciences
- BUY — Kunal Hasmukhlal Shah6 Nov 2026 · ~2 weeks · target ₹1,700 · Target hit
- BUY — MarketSmith India2 Nov 2026 · ~3 months · target ₹1,790 · Target hit
- BUY — Rajesh Satpute30 Oct 2026 · Same day · target ₹1,550 · Target hit
- BUY — Shrikant Chouhan, Kotak Securities30 Oct 2026 · ~2 weeks · target ₹1,575 · Target hit
- BUY — Vikas Salunkhe, Nirmal Bang Securities29 Oct 2026 · ~1 year · target ₹1,620 · Target hit
More from Rajesh Satpute
- BUY Zensar Technologies6 Nov 2026 · ~2 weeks · target ₹610 · Active
- BUY Karur Vysya Bank6 Nov 2026 · Same day · target ₹370 · Target hit
- BUY SBI Life Insurance Company5 Nov 2026 · Same day · target ₹1,760 · Expired
- BUY One 97 Communications5 Nov 2026 · ~2 weeks · target ₹1,850 · Active
- BUY Mankind Pharma5 Nov 2026 · Same day · target ₹2,600 · SL hit

